🚀Enjoy a 7-Day Free Trial Until Jul 20, 2024!

IN

Inogen IncNASDAQ INGN Stock Report

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is INGN undervalued compared to its fair value?

The fair value of INGN stock is hidden USD. Relative to the market price of 9.01 USD Inogen Inc is hidden.

Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The co...[More about valuation]

Inogen Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.212 $B

Price:

9.01 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.623

FINANCIALS

Inogen financial for reporting period

Income Statement

0.078 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.078 B 100%
0.034 B 44%
-0.015 B -20%
-0.015 B -19%

Balance Sheet

0.32 B
0.19 B

Financial Position Analysis

Assets

0.32 B
Current Assets
0.2 B
Total non-current assets
0.12 B

Total current liabilities
0.074 B
Total non-current liabilities
0.05 B

Cash Flow Statement

-0.0089 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0047 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Inogen fundamental analysis for trailing twelve months (TTM)

Profitability score


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-43 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-47 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-28 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is INGN attractive for investment based on fundamental analysis?

INGN stock rating is hidden. Inogen is a hidden by Eyestock methodology.

Get INGN Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-30

Gross Margin:

41

CFO / Debt ratio:

hidden

Current ratio:

3.384

Debt / Equity ratio:

ROE:

-43

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

INGN analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for INGN to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Inogen Inc competitors

AB

ABT

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Par...

Discover

IS

ISRG

Intuitive Surgical Inc

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company i...

Discover

SY

SYK

Stryker Corp

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. The company is ...

Discover

Inogen Inc dividends

INGN dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About INGN stock

About the company Inogen Inc

Market cap $B

0.212

Dividend yield

Shares outstanding

22.9696 B

Inogen, Inc. engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 1,026 full-time employees. The company went IPO on 2014-02-14. The firm primarily develops, manufactures and markets portable oxygen concentrators (POCs) used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The firm's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The firm's Inogen One systems reduce the patients reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen, thereby improving patient quality of life and fostering mobility. Inogen Connect, a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers.

INGN profile

  • Ticker

    INGN

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    14 February 2014

  • Sector

    Healthсare

  • Industry

    Health Care Equipment & Supplies

  • Employees

    1026

  • City

    Goleta

  • Address

    326 Bollay Dr

  • Cusip

    45780L104